Research Paper Volume 13, Issue 11 pp 15444—15458

Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas

class="figure-viewer-img"

Figure 5. Subgroup analysis showed the association between immunotherapy predictive biomarkers and RTK/Ras/PI3K/AKT pathway.